Panagora Asset Management
RPRX icon

Panagora Asset Management’s Royalty Pharma RPRX Stock Holding History

Panagora Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-240,184
Closed -$13.5M – 1301
2026
Q2 		$13.5M Buy
+240,184
New +$12.5M 0.04% 305
2025
Q2 		– Sell
-49,438
Closed -$1.54M – 1202
2025
Q1 		$1.54M Sell
49,438
-14,226
-22% -$451K 0.01% 578
2024
Q4 		$1.62M Buy
63,664
+544
+0.9% +$14.4K 0.01% 560
2024
Q3 		$1.79M Hold
63,120
– – 0.01% 556
2024
Q2 		$1.66M Sell
63,120
-129,378
-67% -$3.59M 0.01% 569
2024
Q1 		$5.85M Sell
192,498
-88,517
-31% -$2.61M 0.03% 309
2023
Q4 		$7.89M Buy
281,015
+215,142
+327% +$5.91M 0.04% 255
2023
Q3 		$1.79M Buy
65,873
+16,525
+33% +$491K 0.01% 561
2023
Q2 		$1.52M Hold
49,348
– – 0.01% 645
2023
Q1 		$1.78M Buy
49,348
+17,778
+56% +$659K 0.01% 616
2022
Q4 		$1.25M Sell
31,570
-19,088
-38% -$797K 0.01% 801
2022
Q3 		$2.04M Sell
50,658
-66,325
-57% -$2.83M 0.01% 593
2022
Q2 		$4.92M Buy
116,983
+105,620
+930% +$4.33M 0.03% 385
2022
Q1 		$443K Hold
11,363
– – ﹤0.01% 1251
2021
Q4 		$453K Hold
11,363
– – ﹤0.01% 1255
2021
Q3 		$411K Sell
11,363
-2,498
-18% -$97.1K ﹤0.01% 1390
2021
Q2 		$568K Sell
13,861
-1,647
-11% -$70.1K ﹤0.01% 1277
2021
Q1 		$676K Buy
15,508
+8,349
+117% +$396K ﹤0.01% 1187
2020
Q4 		$358K Buy
+7,159
New +$304K ﹤0.01% 1354

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Panagora Asset Management's RPRX Position: Q3 2026 in Review

Panagora Asset Management sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 240,184 shares — an estimated $13.5M sold.

Panagora Asset Management first reported a position in RPRX in Q4 2020 and held it in 19 quarters. The position peaked at $13.5M in Q2 2026. 573 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Panagora Asset Management reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
  • Panagora Asset Management sold 240,184 Royalty Pharma shares in Q3 2026, an estimated $13.5M.
  • Panagora Asset Management first reported a position in Royalty Pharma in Q4 2020 and held it in 19 quarters.
  • Panagora Asset Management's Royalty Pharma position peaked at $13.5M in Q2 2026.
  • 573 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Panagora Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.